196 related articles for article (PubMed ID: 34678603)
21. Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors.
Ayoup MS; Ammar A; Abdel-Hamid H; Amer A; Abu-Serie MM; Nasr SA; Ghareeb DA; Teleb M; Tageldin GN
Bioorg Chem; 2024 Feb; 143():107102. PubMed ID: 38211551
[TBL] [Abstract][Full Text] [Related]
22. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
23. Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors.
Osmaniye D; Kurban B; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771054
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors.
Can NÖ; Osmaniye D; Levent S; Sağlık BN; Korkut B; Atlı Ö; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2018 Jan; 144():68-81. PubMed ID: 29248751
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted chalcones as selective and reversible inhibitors of human monoamine oxidase B.
Kong Z; Sun D; Jiang Y; Hu Y
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1513-1523. PubMed ID: 32705910
[TBL] [Abstract][Full Text] [Related]
26. New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.
Pan ZX; He X; Chen YY; Tang WJ; Shi JB; Tang YL; Song BA; Li J; Liu XH
Eur J Med Chem; 2014 Jun; 80():278-84. PubMed ID: 24793878
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors.
Osmaniye D; Evren AE; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100450. PubMed ID: 34931332
[TBL] [Abstract][Full Text] [Related]
28. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
[TBL] [Abstract][Full Text] [Related]
30. Umbelliferone derivatives exert neuroprotective effects by inhibiting monoamine oxidase A, self-amyloidβ aggregation, and lipid peroxidation.
Seong SH; Ali MY; Jung HA; Choi JS
Bioorg Chem; 2019 Nov; 92():103293. PubMed ID: 31557622
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, monoamine oxidase inhibition and docking studies of new dithiocarbamate derivatives bearing benzylamine moiety.
Kaya Çavuşoğlu B; Sağlık BN; Özkay Y; İnci B; Kaplancıklı ZA
Bioorg Chem; 2018 Feb; 76():177-187. PubMed ID: 29175589
[TBL] [Abstract][Full Text] [Related]
32. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
[TBL] [Abstract][Full Text] [Related]
35. Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Tok F; Uğraş Z; Sağlık BN; Özkay Y; Kaplancıklı ZA; Koçyiğit-Kaymakçıoğlu B
Bioorg Chem; 2021 Jul; 112():104917. PubMed ID: 33932769
[TBL] [Abstract][Full Text] [Related]
36. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
38. Potent and Selective Monoamine Oxidase-B Inhibitory Activity: Fluoro- vs. Trifluoromethyl-4-hydroxylated Chalcone Derivatives.
Mathew B; Mathew GE; Uçar G; Baysal I; Suresh J; Mathew S; Haridas A; Jayaprakash V
Chem Biodivers; 2016 Aug; 13(8):1046-52. PubMed ID: 27402375
[TBL] [Abstract][Full Text] [Related]
39. Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase.
Haider S; Alhusban M; Chaurasiya ND; Tekwani BL; Chittiboyina AG; Khan IA
Future Med Chem; 2018 Jun; 10(12):1435-1448. PubMed ID: 29788780
[TBL] [Abstract][Full Text] [Related]
40. Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation.
Kumar S; Jaiswal S; Gupta SK; Ayyannan SR
J Biomol Struct Dyn; 2024 Jun; 42(9):4710-4729. PubMed ID: 37345530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
